Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;134(3):e222-e223.
doi: 10.1016/j.amjmed.2020.10.036.

The Reply

Affiliations
Comment

The Reply

Peter A McCullough. Am J Med. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

  • The Reply.
    McCullough PA. McCullough PA. Am J Med. 2021 Apr;134(4):e298. doi: 10.1016/j.amjmed.2020.11.028. Am J Med. 2021. PMID: 33888224 Free PMC article. No abstract available.
  • The Reply.
    McCullough PA. McCullough PA. Am J Med. 2021 May;134(5):e346-e347. doi: 10.1016/j.amjmed.2021.01.013. Am J Med. 2021. PMID: 33962710 Free PMC article. No abstract available.
  • The Reply.
    McCullough PA. McCullough PA. Am J Med. 2021 May;134(5):e343-e344. doi: 10.1016/j.amjmed.2021.01.011. Am J Med. 2021. PMID: 33962708 Free PMC article. No abstract available.
  • Engaging and Empowering the Front Lines During the COVID-19 Outpatient Practice Reactivation.
    Lucchinetti CF, von Bormann AG, Nagel JJ, Jones AE, O'Horo JC, Callstrom MR; SMaRT Executive Committee. Lucchinetti CF, et al. Mayo Clin Proc. 2020 Sep;95(9S):S47-S51. doi: 10.1016/j.mayocp.2020.06.040. Epub 2020 Jun 30. Mayo Clin Proc. 2020. PMID: 32807527 Free PMC article. Review. No abstract available.
  • ICS haben wohl einen Platz in der ambulanten Covid-Versorgung.
    Nilius G. Nilius G. MMW Fortschr Med. 2022 Jan;164(1):24-26. doi: 10.1007/s15006-021-0542-z. MMW Fortschr Med. 2022. PMID: 35043319 Free PMC article. Review. German. No abstract available.

Cited by

References

    1. McCullough PA, Kelly RJ, Ruocco G. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2021;134:16–22. - PMC - PubMed
    1. Ladapo J, McKinnon JE, McCullough PA, Risch H. Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID-19 infection, hospitalization, and death: meta-analysis [e-pub ahead of print]. MedRxiv. Accessed December 24, 2020. doi: 10.1101/2020.09.30.20204693. - DOI
    1. McCullough PA. Favipiravir and the need for early ambulatory treatment of SARS-CoV2 Infection (COVID-19) Antimicrob Agents Chemother. 2020;64:e02017–e02020. doi: 10.1128/AAC.02017-20. - DOI - PMC - PubMed
    1. Agrawal U, Raju R, Udwadia ZF. Favipiravir: a new and emerging antiviral option in COVID-19. Med J Armed Forces India. 2020;76:370–376. doi: 10.1016/j.mjafi.2020.08.004. - DOI - PMC - PubMed
    1. Gupta A, Chander Chiang K. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease. Med Hypotheses. 2020;143 doi: 10.1016/j.mehy.2020.110122. - DOI - PMC - PubMed